mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |